HESI RN 301 Pharmacology Final Exam | Nurselytic

Questions 51

HESI RN

Home > HESI RN > HESI Pharmacology > HESI RN 301 Pharmacology Final Exam
HESI RN Test Bank

HESI RN 301 Pharmacology Final Exam Questions

Extract:


Question 1 of 5

The nurse is administering the angiotensin II receptor antagonist valsartan. Which physiological response causes its therapeutic effect?

Correct Answer: C

Rationale: Valsartan blocks angiotensin II, causing vasodilation to lower blood pressure. It doesn’t affect heart rate (chronotropic), cause diuresis, or act sympatholytically.

Question 2 of 5

Correct Answer:

Rationale:

Question 3 of 5

Correct Answer:

Rationale:

Question 4 of 5

Correct Answer:

Rationale:

Question 5 of 5

Correct Answer:

Rationale:

Similar Questions

A client is using the nasal spray hormone calcitonin to reduce bone loss from osteoporosis. To reduce rhinitis associated with administration of the nasal spray, the nurse should provide the client with which instruction?
The nurse is planning discharge teaching for a client with type 2 diabetes mellitus who has a new prescription for insulin glargine. Which action should the nurse plan to include in the discharge teaching?
Prior to administering oral doses of calcitriol and calcium carbonate to a client with hypoparathyroidism, the nurse notes that the client's total calcium level is 14 mg/dl (3.5 mmol/l). Which action should the nurse implement?
An increase in which serum lab value indicates to the nurse that a prescription for atorvastatin is having the desired effect for a client at risk for coronary artery disease?
The nurse is assessing a client who was recently diagnosed with Parkinson's disease (PD) and is taking carbidopa-levodopa. The client is concerned that the medication is not working. Which intervention should the nurse implement first?

Access More Questions!

HESI RN Basic

$89/ 30 days

 

HESI RN Premium

$150/ 90 days